Submission Guidelines

Submission Guidelines for WritePharma Publications

​

WritePharma welcomes original submissions to both our open-access Drug Information Blog and our peer-reviewed journal, Scriptum Pharmacologia (J Scrip Pharm). Articles should be written in accordance with American Medical Association (AMA) style, which emphasizes clarity, structure, and evidence-based communication. AMA style requires the use of active voice, proper grammar, and full citations formatted numerically in the order of appearance within the text. References should be listed at the end of the article in AMA format, including author names (up to six before “et al.”), article title in sentence case, abbreviated journal name, year, volume, and inclusive page numbers. Authors must avoid footnotes and use superscript Arabic numerals for in-text citations. All submissions should be formatted with justified text, 1.0–1.5 line spacing, and standard fonts (e.g., Times New Roman, 12 pt).

​

The Drug Information Blog serves as an accessible resource for the general public and healthcare consumers, offering informative articles on a broad range of health and medicine topics. Content may adopt a more conversational tone while maintaining scientific accuracy and appropriate citation. By contrast, Scriptum Pharmacologia publishes scholarly, expert-level articles centered on investigational pharmacotherapy, complex pharmacokinetics, and emerging advances in personalized medicine. Submissions to Scriptum should demonstrate scientific rigor, critical analysis, and familiarity with relevant literature.

​

All accepted works will be published online with author credit and assigned a Digital Object Identifier (DOI). Please allow sufficient time for review, particularly for peer-reviewed journal submissions. Authors are responsible for ensuring originality, accuracy, and compliance with our ethical standards, which are detailed at www.scriptumpharm.org/ethics.

 

WritePharma adheres to strict publication ethics and reserves the right to reject or request revision of any material that does not meet our standards for quality, transparency, and integrity.